Clinical Trial Update: The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of luspatercept to improve early anemia after hematopoietic stem cell transplantation; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• REBLOZYL (LUSPATERCEPT)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: HSCT | Phase 2 | Status: NOT_YET_RECRUITING